Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymph Node Dissection for Small Renal Masses.

Michael L Blute1, Mohit Gupta1, Paul L Crispen1

  • 1Department of Urology, University of Florida College of Medicine, Gainesville, FL, USA.

The Urologic Clinics of North America
|April 17, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ellis-van Creveld Syndrome: Common Atrium with Post-axial Polydactyly.

QJM : monthly journal of the Association of Physicians·2026
Same author

When the left ventricle dances: ballerina foot appearance in hypertrophic cardiomyopathy.

The Journal of invasive cardiology·2026
Same author

Early LDL-C Lowering Efficacy of High-intensity Atorvastatin and Ezetimibe Combination Compared with High-intensity Atorvastatin Alone in Acute Coronary Syndrome: The LAI EARLY ACS Study.

The Journal of the Association of Physicians of India·2026
Same author

Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: Toxicity.

Advances in radiation oncology·2026
Same author

<sup>89</sup>Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell Carcinoma.

Pharmaceutics·2026
Same author

A Randomized Feasibility Trial of a Multicomponent Quality Improvement Strategy for Chronic Care of Cardiovascular Diseases: Findings from the C-QIP Trial in India.

medRxiv : the preprint server for health sciences·2026
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Lymph node dissection is not routinely recommended for small renal masses (SRMs) under 4 cm due to low metastatic potential. However, it may benefit patients with high-risk features or lymphadenopathy for improved staging and survival.

Area of Science:

  • Urology
  • Surgical Oncology
  • Renal Cell Carcinoma Research

Background:

  • Small renal masses (SRMs), defined as <4 cm, typically have low metastatic potential.
  • Standard treatments for SRMs include radical or partial nephrectomy.
  • The necessity of lymph node dissection (LND) during surgery for SRMs remains uncertain.

Purpose of the Study:

  • To evaluate the role and impact of lymph node dissection in the surgical management of small renal masses.
  • To determine if LND provides a survival benefit for patients with clinically localized renal cell carcinoma.
  • To identify specific patient subgroups who might benefit from LND.

Main Methods:

  • Review of a randomized trial comparing survival with and without lymph node dissection in clinically localized renal cell carcinoma.
Keywords:
Lymph node dissection (LND)Renal cell carcinoma (RCC)Small renal mass (SRM)

Related Experiment Videos

  • Analysis of the potential benefits of LND for staging and survival in SRMs with high-risk features or lymphadenopathy.

    • Main Results:

    • A randomized trial found no survival advantage from LND in clinically localized renal cell carcinoma.
    • LND is not recommended as a routine procedure for SRMs.
    • LND may offer improved local staging and potential survival benefits in select cases with high-risk features or lymphadenopathy.

    Conclusions:

    • Routine lymph node dissection is not indicated for small renal masses.
    • Consider LND for SRMs in patients with high-risk features or radiographic evidence of lymphadenopathy.
    • Lymph node dissection templates should align with known renal lymphatic drainage patterns when performed.